Assessing Dynamic Reading Behaviors Using Eye-Tracking Tobii Glasses
NCT ID: NCT05684224
Last Updated: 2024-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10 participants
OBSERVATIONAL
2022-12-14
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Horizontal convergence tracked with Tobii glasses is a reliable substitute for accommodation in young myopes and hyperopes with normal accommodative amplitudes
2. Young mypopes and hyperopes demonstrate different reading behaviors during near work
AIMS \& OBJECTIVES:
1. Compare the accommodative responses measured with the Grand Seiko open-field autorefractor to those derived from the Tobii Glasses, when subjects wear (1) spectacle glasses, (2) single vision contact lenses (SVCLs), and (3) multifocal contact lenses (MFCLs).
2. Investigate subjects' natural and dynamic accommodative behaviors and eye postures during reading using the Tobii Glasses.
3. Compare the change in natural and dynamic accommodative behaviors and eye postures during reading between myopes and hyperopes using the Tobii Glasses.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myopia Prevention With Reading Glasses
NCT05030103
Dynamic Change in Accommodation After Wearing Multifocal Soft Contact Lenses for Myopia Control
NCT04763694
Assessment of Corneal Biomechanics With the Corvis ST in Different Age of Myopia With Orthokeratology
NCT05635526
Effect of Biofeedback Training on Accommodation During Multifocal Lens Wear in Young Adults
NCT05684250
Effect of Peripheral Defocus on Axial Growth in Hyperopes
NCT02686879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Various optical and pharmacological interventions have been developed to prevent the progression of childhood myopia, including specially-designed spectacles, multifocal contact lenses, orthokeratology, and low concentration atropine eye drops. However, no treatment is 100% effective; 20% of myopic children on treatment progress as if they were not being treated, and more than 50% of treated children still demonstrate significant progression. Accurate quantification of the visual environment and behavior of myopic children and the impact on treatment efficacy will guide clinicians on risk management and improve responses to existing treatments for progressive myopia. Multifocal soft contact lens (MFCL) with central distance correction and a peripheral plus power profile is an effective treatment strategy for myopia control in children, with variable efficacies. One possible explanation is that children wearing these lenses under-accommodate at near which could reduce the lenses' treatment effect. It would be important to track the dynamic reading behaviors to better understand how accommodation and other binocular functions may change during reading. As of now, no portal devices can track dynamic accommodation. Tobii glasses are wearable eye trackers that accurately record horizontal and vertical vergences, pupil size, and reading distance over time. Investigator's pilot data shows that horizontal convergence can be used as a substitute for accommodation in subjects with normal accommodative amplitudes and eye posture. This study aims to compare the accuracy of accommodative measurements obtained with the Grand Seiko open-field autorefractor and the Tobii Glasses, when subjects wear (1) spectacle glasses, (2) single vision contact lenses (SVCLs), and (3) MFCLs. This study will also track the subject's natural reading behavior.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dynamic accommodation
Dynamic accommodation will be tracked using the Tobii Glasses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Refractive error: Subjects with myopia between -1.00 and -5.00 D in each eye (n = 5), or hyperopia between +2.00 and +5.00 D in each eye (n = 5), determined by spherical equivalent using dry manifest refraction and binocular balance
3. Astigmatism \<= 0.75 D in each eye
4. Anisometropia \<= 1.50 D
5. BCVA at distance 20/20 in each eye
6. Habitual contact lens wears or willing to wear single vision and multifocal contact lenses during the 2nd study visit
7. Normal eye posture and accommodation
8. Good general and ocular health
Exclusion Criteria
2. Amblyopia
3. Significant anisometropia (\>1.50 D)
18 Years
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State University of New York College of Optometry
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaoying Zhu, OD, PhD, MD, MS, FAAO
Associate Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xiaoying Zhu
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRBNET.ORG 1921452
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.